How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers [PDF]
Seminars in Nuclear MedicineThis expedited systematic review aims to provide the first overview of the different Fibroblast activation protein inhibitor (FAPI) PET scan procedures in the literature and discuss how to efficiently obtain optimal FAPI PET images based on the best available evidence.
Morten Bentestuen +3 more
core +5 more sources
FAPI-04 Uptake in Healthy Tissues of Cancer Patients in 68Ga-FAPI-04 PET/CT Imaging
Contrast Media & Molecular Imaging, 2021 Objective. The aim of this study is to investigate the uptake of 68Ga-FAPI-04 in normal tissues and calculate standardized uptake values (SUVs) for various organs in the body. Methods. A total of 49 patients who underwent 68Ga-FAPI-04 PET/CT were included in our study. The following organs were identified on CT images: brain, parotid, and submandibular
Cihan Gündoğan +4 more
openaire +4 more sources
This chapter describes the interesting role of PET with radiolabeled fibroblast activation protein inhibitors (FAPIs), underlining the potential clinical indications. Furthermore, the emerging role of FAPI PET is highlighted with interesting clinical cases.
Cimini, Andrea +8 more
openaire +2 more sources
Formal security analysis of the OpenID FAPI 2.0 Security Profile with FAPI 2.0 Message Signing, FAPI-CIBA, Dynamic Client Registration and Management : technical report [PDF]
, 2023 Building on our recent formal security analysis of the FAPI 2.0 Security Profile, we here extend the analysis effort to FAPI 2.0 Message Signing, combined with Dynamic Client Registration, Dynamic Client Management, and FAPI-CIBA. Overall, we model an ecosystem which uses all these profiles and extensions in parallel. Like the previous work on the FAPI
Hosseyni, Pedram +2 more
openaire +4 more sources
FAPI PET/CT Imaging—An Updated Review
Diagnostics, 2023 Despite revolutionizing the field of oncological imaging, Positron Emission Tomography (PET) with [18F]Fluorodeoxyglucose (FDG) as its workhorse is limited by a lack of specificity and low sensitivity in certain tumor subtypes. Fibroblast activation protein (FAP), a type II transmembrane glycoprotein, is expressed by cancer-associated fibroblasts (CAFs)
Kunal Ramesh Chandekar +3 more
openaire +4 more sources
Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions. [PDF]
, 2022 68Ga-labeled fibroblast activation protein (FAP) inhibitor (68Ga-FAPI) PET targets 68Ga-FAPI-positive activated fibroblasts and is a promising imaging technique for various types of cancer and nonmalignant pathologies.
Liew, Dawn P +14 more
core +2 more sources
, 2022 Supplementary Table from Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer ...
Lale Umutlu (15043809) +17 more
core +4 more sources
, 2022 Supplementary Data from Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI ...
Ellen Puré (14935301) +14 more
core +3 more sources
Locoregional radionuclide therapy of glioblastoma with [211At]At-PDA-FAPI
Scientific ReportsGlioblastoma is the most common and aggressive tumor of the central nervous system. Locoregional administration of therapeutic radiopharmaceuticals appears to be a promising modality for recurrent glioblastomas.
Huan Ma +8 more
doaj +2 more sources
Ga68-FAPI Imaging and Lu177-FAPI Therapy in a Case of Metastatic Solitary Fibrous Tumor
Indian Journal of Nuclear Medicine, 2023 Solitary fibrous tumor (SFT) of the central nervous system (previously called hemangiopericytoma) is a rare mesenchymal tumor. Malignant SFT has a tendency to recur after surgery and can metastasize to distant organs. Treatment options for metastatic disease are limited.
Luthra, Karuna +2 more
openaire +2 more sources